An official website of the United States government
          Here’s how you know
        Here’s how you know**Official websites use .gov**A
              **.gov** website belongs to an official government
              organization in the United States.
        **Secure .gov websites use HTTPS**A
              **lock** (
              Locked padlock icon) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
 Top Utility Nav
        
        
        Asian-Language Resources
        
        Portal en español


Site search Mega Menu
  

        

        Home
                  Health Topics
                                      
    
  Health Topics

    Arthritis and Rheumatic Diseases
          
    Muscle and Bone Diseases
          
    Skin Diseases
          
    All Diseases and Conditions
          
    Publication Catalog
                  Grants & Funding
                                      
    
  Grants & Funding

    Current Funding Opportunities
          
    Supported Scientific Programs
          
    NIAMS-Supported Programs
          
    Applying for a Grant
          
    NIH Policies and Guidance
          
    Peer Review and Grants Administration Resources
          
    Types of Funding Mechanisms (Activity Codes)
                  Labs @ NIAMS
                                      
    
  Labs @ NIAMS

    NIAMS Labs and Core Facilities
          
    Research Faculty
          
    Research Areas
          
    NIAMS Scientific Advances
          
    Training and Career Development
                  Clinical Trials
                                      
    
  Clinical Trials
      
            For Principal Investigators

    Clinical Trial Policies, Guidelines, and Templates
          
    Conducting Clinical Trials
          
    Register with ClinicalTrials.gov

For Patients

What is a Clinical Trial?
	Clinical Trials at NIAMS
	Clinical Trials in the Spotlight
                  News & Events
                                      
    
  Newsroom

    All NIAMS News
          
    NIAMS Newsletters
          
    Meetings & Events
                  About NIAMS
                                      
    
  About NIAMS

    Director's Page
          
    NIAMS Organization
          
    Strategic Plan Fiscal Years 2020-2024
          
    Staff Directory
          
    NIAMS Budget
          
    Partnerships
          
    Contact NIAMS
                  Community Outreach
                                      
    
  Community Outreach

    Bone Health
          
    Joint Health
          
    Muscle, Tendon, and Ligament Health
          
    Skin Health
          
    Health Information For Kids And Young Adults
          
    Health Information For Older Adults/Seniors
          
    Printable Materials for Community Events
          
    Resources in Other Languages
          
    Annual Health Observances
          
    Social Media Resources Breadcrumb
    Home
          About NIAMS
          Herbert S.B. Baraf, M.D.





Herbert S.B. Baraf, M.D.


Special Volunteer
    Clinical Care and Research Image
              Headshot of Herbert Baraf 
            Contact Information

                                
                                                9000 Rockville Pike
                  
            10 Center Drive
      
                  
            Building 10
      
                                   Bethesda MD 20892
                
                                                Herbert.Baraf@NIH.gov 
                Summary
          Herbert S. B. Baraf, M.D., is a founder of Arthritis and Rheumatism Associates, the Washington, D.C., region’s largest private practice rheumatology group. He is also the founding medical director of The Center for Rheumatology and Bone Research. He retired from private practice in 2022.

Dr. Baraf holds academic appointments as a Clinical Professor of Medicine at George Washington University in Washington, DC, and an Associate Clinical Professor at the University of Maryland in Baltimore. He earned his medical degree from the State University of New York Downstate Medical Center and completed his internship and residency at George Washington University. He completed a fellowship in rheumatology at Duke University.

He has served as principal investigator on over 300 clinical trials in rheumatology, with a particular interest in gouty arthritis. Dr. Baraf was designated as a Master of the American College of Rheumatology, and in 2014 he was awarded the ACR’s Paulding Phelps Award for service to patients and the profession. He is the 2022 awardee for the ACR’s Innovation in Clinical Care Award.
        
                  Research Statement
          
            I have participated in clinical trials related to the therapy of gout, rheumatoid arthritis, psoriatic arthritis, degenerative joint disease, systemic lupus erythematosus, and Sjogren’s syndrome. 

            Scientific Publications
              Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response.

    Botson JK, Baraf HSB, Keenan RT, Albert J, Masri KR, Peterson J, Yung C, Freyne B, Amin M, Abdellatif A, Soloman N, Edwards NL, Strand V
        

                    Curr Rheumatol Rep.
        
                    2022 Jan;
        
                    24(1).
        
                    doi: 10.1007/s11926-022-01055-9
                            PMID: 35167037
  Effects of Conventional Uric Acid-Lowering Therapy on Monosodium Urate Crystal Deposits.

    Ellmann H, Bayat S, Araujo E, Manger B, Kleyer A, Cavallaro A, Lell M, Schenker H, Simon D, Tascilar K, Baraf HSB, Schett G, Rech J
        

                    Arthritis Rheumatol.
        
                    2020 Jan;
        
                    72(1).
        
                    doi: 10.1002/art.41063
                            PMID: 31353871
  Use of Pre-Infusion Serum Uric Acid Levels as a Biomarker for Infusion Reaction Risk in Patients on Pegloticase.

    Keenan RT, Baraf HSB, LaMoreaux B
        

                    Rheumatol Ther.
        
                    2019 Jun;
        
                    6(2).
        
                    doi: 10.1007/s40744-019-0151-9
                            PMID: 30875075
  Update on imaging in gout: contrasting and comparing the role of dual-energy computed tomography to traditional diagnostic and monitoring techniques.

    Bayat S, Baraf HSB, Rech J
        

                    Clin Exp Rheumatol.
        
                    2018 Sep-Oct;
        
                    36 Suppl 114(5).
  Exploratory study of radiographic change in patients with tophaceous gout treated with intensive urate-lowering therapy.

    Dalbeth N, Doyle AJ, McQueen FM, Sundy J, Baraf HS
        

                    Arthritis Care Res (Hoboken).
        
                    2014 Jan;
        
                    66(1).
        
                    doi: 10.1002/acr.22059
                            PMID: 23836458
  Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy.

    Baraf HS, Becker MA, Gutierrez-Urena SR, Treadwell EL, Vazquez-Mellado J, Rehrig CD, Ottery FD, Sundy JS, Yood RA
        

                    Arthritis Res Ther.
        
                    2013 Sep 26;
        
                    15(5).
        
                    doi: 10.1186/ar4318
                            PMID: 24286509
  Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator.

    Terkeltaub RA, Schumacher HR, Carter JD, Baraf HS, Evans RR, Wang J, King-Davis S, Weinstein SP
        

                    Arthritis Res Ther.
        
                    2013 Feb 1;
        
                    15(1).
        
                    doi: 10.1186/ar4159
                            PMID: 23375025
  Long-term safety of pegloticase in chronic gout refractory to conventional treatment.

    Becker MA, Baraf HS, Yood RA, Dillon A, Vázquez-Mellado J, Ottery FD, Khanna D, Sundy JS
        

                    Ann Rheum Dis.
        
                    2013 Sep 1;
        
                    72(9).
        
                    doi: 10.1136/annrheumdis-2012-201795
                            PMID: 23144450 
          Experience
              
            **Clinical Professor of Medicine**George Washington University (1996 to present)**Founding Medical Director**Center for Rheumatology and Bone Research  (1981-2022)**Founder and Principal Physician**Arthritis and Rheumatism Associates  (1978-2022)


Last Updated: January 2024


Back to Top
 About NIAMS
                    Clinical Trials
                    Grants & Funding
                    Health Topics
                    Labs @ NIAMS
              News Room
                    NIAMS Multimedia Library
                    Disclaimer
                    FOIA
                    Contact us
              Privacy Statement
                    Accessibility
                    HHS Vulnerability Disclosure
                    Social Media Moderation Policy
                    NIAMS Archives
        Subscribe to Our E-Newsletters
            Click the button to see different options to sign up for newsletters.
            Click Here to Subscribe
          Follow us on
  
  About NIH
                  Accessibility Support
            FOIA requests
                  No FEAR Act data
            Office of the Inspector General
                  Performance reports
            Privacy Policy